Investigation of allergic reaction during the treatment of anti-TNF alpha monoclonal antibody in patients with inflammatory bowel diseases

Investigation of allergic reaction during the treatment of anti-TNF alpha monoclonal antibody in patients with inflammatory bowel diseases - Investigation of allergic reaction in anti-TNF alpha monoconal antibody- treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010508

Enrollment

Registered

2013-05-01

Start date

2013-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory boewl diseases

Interventions

Allergic group for anti-TNF aplha monoclonal antibody non allergic group for anti-TNF aplha monoclonal antibody

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: IBD patients who had or will have a informed consent of clinical study of UMIN000005032

Exclusion criteria

Exclusion criteria: Patients without informed consent

Design outcomes

Primary

Measure	Time frame
Investigation of biomarker	—

Countries

Japan

Contacts

Public ContactShingo Kato

Saitama Medical Center, Saitama Medical University Department of Gastroenterology and Hepatology

skato@saitama-med.ac.jp049-228-3564

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026